GNR-084

Clinical trials for GNR-084 explained in plain language.

Never miss a new study

Get alerted when new GNR-084 trials appear

Sign up with your email to follow new studies for GNR-084, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental antibody GNR-084 tested against Hard-to-Treat leukemia

Disease control Stopped early

Researchers are testing an experimental antibody called GNR-084 in adults with B-cell acute lymphoblastic leukemia that has come back or stopped responding to treatment. The trial enrolls 14 people aged 18 to 45 who have already received at least two prior therapies. Participants…

Matched conditions: GNR-084

Phase 1/2 • Sponsor: AO GENERIUM • Aim: Disease control

Last updated Sep 22, 2026 01:00 UTC

GNR-084

Get alerted when new GNR-084 trials appear

Experimental antibody GNR-084 tested against Hard-to-Treat leukemia